Unanue E R, Karnovsky M J
J Exp Med. 1974 Nov 1;140(5):1207-20. doi: 10.1084/jem.140.5.1207.
Capping of surface Ig by anti-Ig antibodies involves a membrane perturbation requiring an energy-dependent step. Lymphocytes treated with anti-Ig are stimulated to move. Previously, we had shown that movement was not essential for capping, although it influenced the localization of the cap. We have investigated the role of cell movement and of microtubular proteins in this phenomenon. Treatment of B lymphocytes with colchicine does not affect capping of Ig nor does it affect the increase in translational movement produced by anti-Ig antibodies. Treatment of lymphocytes with cytochalasin B stops translational movement and may affect capping to some degree under appropriate circumstances. Lymphocytes treated with both drugs are impaired in capping. We surmise that there may be two cytoplasmic events regulating directly or indirectly capping: one associated with the process of translational movement, the other associated with the activity of microtubules. Lymphocytes treated with concanavalin A do not cap Ig. Colchicine reverses this inhibition. Certain experimental procedures antagonize the colchicine effect, the most striking of which is the use of cytochalasin B. Colchicine appears to increase movement of the Con A-treated lymphocyte, and this increased movement appears responsible for the accumulation of complexes to the posterior part of the cell. Con A inhibits patching of Ig by anti-Ig, and this is not reversed by colchicine.
用抗免疫球蛋白抗体封盖表面免疫球蛋白涉及一种需要能量依赖步骤的膜扰动。用抗免疫球蛋白处理的淋巴细胞会被刺激而移动。此前,我们已经表明移动对于封盖并非必不可少,尽管它会影响帽的定位。我们研究了细胞移动和微管蛋白在这一现象中的作用。用秋水仙碱处理B淋巴细胞既不影响免疫球蛋白的封盖,也不影响抗免疫球蛋白抗体产生的平移运动增加。用细胞松弛素B处理淋巴细胞会停止平移运动,并且在适当情况下可能会在一定程度上影响封盖。用这两种药物处理的淋巴细胞在封盖方面受损。我们推测可能有两个细胞质事件直接或间接调节封盖:一个与平移运动过程相关,另一个与微管的活性相关。用刀豆球蛋白A处理的淋巴细胞不会封盖免疫球蛋白。秋水仙碱可逆转这种抑制作用。某些实验程序会拮抗秋水仙碱的作用,其中最显著的是使用细胞松弛素B。秋水仙碱似乎会增加经刀豆球蛋白A处理的淋巴细胞的移动,而这种增加的移动似乎是复合物在细胞后部积累的原因。刀豆球蛋白A抑制抗免疫球蛋白对免疫球蛋白的斑块形成,而秋水仙碱不能逆转这种抑制作用。